|
1
|
Ouyang H, Zhou Y, Zhang L and Shen G:
Diagnostic value of microRNAs for urologic cancers: A systematic
review and meta-analysis. Medicine. 94:e12722015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD, Fedewa SA, Ahnen DJ,
Meester RGS, Barzi A and Jemal A: Colorectal cancer statistics,
2017. CA Cancer J Clin. 67:177–193. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bao Z, Zhang W and Dong D: A potential
prognostic lncRNA signature for predicting survival in patients
with bladder urothelial carcinoma. Oncotarget. 8:10485–10497. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Berrondo C, Flax J, Kucherov V, Siebert A,
Osinski T, Rosenberg A, Fucile C, Richheimer S and Beckham CJ:
Expression of the long non-coding RNA HOTAIR correlates with
disease progression in bladder cancer and is contained in bladder
cancer patient urinary exosomes. PLoS One. 11:e01472362016.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kang M, Jeong CW, Kwak C, Kim HH and Ku
JH: Preoperative neutrophil-lymphocyte ratio can significantly
predict mortality outcomes in patients with non-muscle invasive
bladder cancer undergoing transurethral resection of bladder tumor.
Oncotarget. 8:12891–12901. 2017.PubMed/NCBI
|
|
6
|
Urquidi V, Netherton M, Gomes-Giacoia E,
Serie DJ, Eckel-Passow J, Rosser CJ and Goodison S: A microRNA
biomarker panel for the non-invasive detection of bladder cancer.
Oncotarget. 7:86290–86299. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Xu X, Wang X, Fu B, Meng L and Lang B:
Differentially expressed genes and microRNAs in bladder carcinoma
cell line 5637 and T24 detected by RNA sequencing. Int J Clin Exp
Pathol. 8:12678–12687. 2015.PubMed/NCBI
|
|
8
|
Falzone L, Candido S, Salemi R, Basile MS,
Scalisi A, McCubrey JA, Torino F, Signorelli SS, Montella M and
Libra M: Computational identification of microRNAs associated to
both epithelial to mesenchymal transition and NGAL/MMP-9 pathways
in bladder cancer. Oncotarget. 7:72758–72766. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cheng Y, Zhang X and Li P, Yang C, Tang J,
Deng X, Yang X, Tao J, Lu Q and Li P: MiR-200c promotes bladder
cancer cell migration and invasion by directly targeting RECK. Onco
Targets Ther. 9:5091–5099. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Egawa H, Jingushi K, Hirono T, Ueda Y,
Kitae K, Nakata W, Fujita K, Uemura M, Nonomura N and Tsujikawa K:
The miR-130 family promotes cell migration and invasion in bladder
cancer through FAK and Akt phosphorylation by regulating PTEN. Sci
Rep. 6:205742016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ding M, Li Y, Wang H, Lv Y, Liang J, Wang
J and Li C: Diagnostic value of urinary microRNAs as non-invasive
biomarkers for bladder cancer: A meta-analysis. Int J Clin Exp Med.
8:15432–15440. 2015.PubMed/NCBI
|
|
12
|
Zhang X, Zhang Y, Liu X, Fang A, Li P, Li
Z, Liu T, Yang Y, Du L and Wang C: MicroRNA-203 is a prognostic
indicator in bladder cancer and enhances chemosensitivity to
cisplatin via apoptosis by targeting Bcl-w and Survivin. PLoS One.
10:e01434412015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Morais DR, Reis ST, Viana N, Piantino CB,
Massoco C, Moura C, Dip N, Silva IA, Srougi M and Leite KR: The
involvement of miR-100 in bladder urothelial carcinogenesis
changing the expression levels of mRNA and proteins of genes
related to cell proliferation, survival, apoptosis and chromosomal
stability. Cancer Cell Int. 14:1192014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wu WB, Wang W, Du YH, Li H, Xia SJ and Liu
HT: MicroRNA-3713 regulates bladder cell invasion via MMP9. Sci
Rep. 6:323742016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cheng S, Liu J, Zhang Y, Lin Y, Liu Q, Li
H, Huang J and Zhang P: Association detection between genetic
variants in the microRNA binding sites of toll-like receptors
signaling pathway genes and bladder cancer susceptibility. Int J
Clin Exp Pathol. 7:8118–8126. 2014.PubMed/NCBI
|
|
16
|
Wang H, Zhang W, Zuo Y, Ding M, Ke C, Yan
R, Zhan H, Liu J and Wang J: miR-9 promotes cell proliferation and
inhibits apoptosis by targeting LASS2 in bladder cancer. Tumour
Biol. 36:9631–9640. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhou M, Wang S, Hu L, Liu F, Zhang Q and
Zhang D: miR-199a-5p suppresses human bladder cancer cell
metastasis by targeting CCR7. BMC Urol. 16:642016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shang A, Yang M, Shen F, Wang J, Wei J,
Wang W, Lu W and Wang C and Wang C: MiR-1-3p suppresses the
proliferation, invasion and migration of bladder cancer cells by
up-regulating SFRP1 expression. Cell Physiol Biochem. 41:1179–1188.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pignot G, Cizeron-Clairac G, Vacher S,
Susini A, Tozlu S, Vieillefond A, Zerbib M, Lidereau R, Debre B,
Amsellem-Ouazana D and Bieche I: microRNA expression profile in a
large series of bladder tumors: Identification of a 3-miRNA
signature associated with aggressiveness of muscle-invasive bladder
cancer. Int J Cancer. 132:2479–2491. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gu W, Gao T, Shen J, Sun Y, Zheng X, Wang
J, Ma J, Hu XY, Li J and Hu MJ: MicroRNA-183 inhibits apoptosis and
promotes proliferation and invasion of gastric cancer cells by
targeting PDCD4. Int J Clin Exp Med. 7:2519–2529. 2014.PubMed/NCBI
|
|
21
|
Yang M, Liu R, Li X, Liao J, Pu Y, Pan E,
Yin L and Wang Y: miRNA-183 suppresses apoptosis and promotes
proliferation in esophageal cancer by targeting PDCD4. Mol Cells.
37:873–880. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ren LH, Chen WX, Li S, He XY, Zhang ZM, Li
M, Cao RS, Hao B, Zhang HJ, Qiu HQ and Shi RH: MicroRNA-183
promotes proliferation and invasion in oesophageal squamous cell
carcinoma by targeting programmed cell death 4. Br J Cancer.
111:2003–2013. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li C, Deng L, Zhi Q, Meng Q, Qian A, Sang
H, Li X and Xia J: MicroRNA-183 functions as an oncogene by
regulating PDCD4 in gastric cancer. Anticancer Agents Med Chem.
16:447–455. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Miao F, Zhu J, Chen Y, Tang N, Wang X and
Li X: MicroRNA-183-5p promotes the proliferation, invasion and
metastasis of human pancreatic adenocarcinoma cells. Oncol Lett.
11:134–140. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sun Y, Cheng H, Wang G, Yu G, Zhang D,
Wang Y, Fan W and Yang W: Deregulation of miR-183 promotes melanoma
development via lncRNA MALAT1 regulation and ITGB1 signal
activation. Oncotarget. 8:3509–3518. 2017.PubMed/NCBI
|
|
26
|
Han Y, Chen J, Zhao X, Liang C, Wang Y,
Sun L, Jiang Z, Zhang Z, Yang R, Chen J, et al: MicroRNA expression
signatures of bladder cancer revealed by deep sequencing. PLoS One.
6:e182862011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yamada Y, Enokida H, Kojima S, Kawakami K,
Chiyomaru T, Tatarano S, Yoshino H, Kawahara K, Nishiyama K, Seki N
and Nakagawa M: MiR-96 and miR-183 detection in urine serve as
potential tumor markers of urothelial carcinoma: Correlation with
stage and grade, and comparison with urinary cytology. Cancer Sci.
102:522–529. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wei S, Bing Z, Yao Y, Master SR and Gupta
P: Higher expression of miR-182 in cytology specimens of high-grade
urothelial cell carcinoma: A potential diagnostic marker. Acta
Cytol. 59:109–112. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Scheffer AR, Holdenrieder S, Kristiansen
G, von Ruecker A, Müller SC and Ellinger J: Circulating microRNAs
in serum: Novel biomarkers for patients with bladder cancer? World
J Urol. 32:353–358. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Robertson AG, Kim J, Al-Ahmadie H,
Bellmunt J, Guo G, Cherniack AD, Hinoue T, Laird PW, Hoadley KA,
Akbani R, et al: Comprehensive molecular characterization of
muscle-invasive bladder cancer. Cell. 171:540–556.e25. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li QQ, Hsu I, Sanford T, Railkar R, Balaji
N, Sourbier C, Vocke C, Balaji KC and Agarwal PK: Protein kinase D
inhibitor CRT0066101 suppresses bladder cancer growth in vitro and
xenografts via blockade of the cell cycle at G2/M. Cell Mol Life
Sci. Oct;25;2017.(Epub ahead of print). doi:
10.1007/s00018-017-2681-z.
|
|
32
|
Robinson MD, McCarthy DJ and Smyth GK:
edgeR: A bioconductor package for differential expression analysis
of digital gene expression data. Bioinformatics. 26:139–140. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zeng JH, Liang L, He RQ, Tang RX, Cai XY,
Chen JQ, Luo DZ and Chen G: Comprehensive investigation of a novel
differentially expressed lncRNA expression profile signature to
assess the survival of patients with colorectal adenocarcinoma.
Oncotarget. 8:16811–16828. 2017.PubMed/NCBI
|
|
34
|
Benito-Martin A and Peinado H: FunRich
proteomics software analysis, let the fun begin. Proteomics.
15:2555–2556. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Pathan M, Keerthikumar S, Ang CS, Gangoda
L, Quek CY, Williamson NA, Mouradov D, Sieber OM, Simpson RJ, Salim
A, et al: FunRich: An open access standalone functional enrichment
and interaction network analysis tool. Proteomics. 15:2597–2601.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Xu F, Zhang H, Su Y, Kong J, Yu H and Qian
B: Up-regulation of microRNA-183-3p is a potent prognostic marker
for lung adenocarcinoma of female non-smokers. Clin Transl Oncol.
16:980–985. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang G, Wang S and Li C: MiR-183
overexpression inhibits tumorigenesis and enhances DDP-induced
cytotoxicity by targeting MTA1 in nasopharyngeal carcinoma. Tumour
Biol. 39:10104283177038252017.PubMed/NCBI
|
|
38
|
Fan D, Wang Y, Qi P, Chen Y, Xu P, Yang X,
Jin X and Tian X: MicroRNA-183 functions as the tumor suppressor
via inhibiting cellular invasion and metastasis by targeting MMP-9
in cervical cancer. Gynecol Oncol. 141:166–174. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhou L, Zhang WG, Wang DS, Tao KS, Song WJ
and Dou KF: MicroRNA-183 is involved in cell proliferation,
survival and poor prognosis in pancreatic ductal adenocarcinoma by
regulating Bmi-1. Oncol Rep. 32:1734–1740. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chen YH, Wang SQ, Wu XL, Shen M, Chen ZG,
Chen XG, Liu YX, Zhu XL, Guo F, Duan XZ, et al: Characterization of
microRNAs expression profiling in one group of Chinese urothelial
cell carcinoma identified by Solexa sequencing. Urol Oncol.
31:219–227. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ichimi T, Enokida H, Okuno Y, Kunimoto R,
Chiyomaru T, Kawamoto K, Kawahara K, Toki K, Kawakami K, Nishiyama
K, et al: Identification of novel microRNA targets based on
microRNA signatures in bladder cancer. Int J Cancer. 125:345–352.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Friedman JM, Liang G, Liu CC, Wolff EM,
Tsai YC, Ye W, Zhou X and Jones PA: The putative tumor suppressor
microRNA-101 modulates the cancer epigenome by repressing the
polycomb group protein EZH2. Cancer Res. 69:2623–2629. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Eissa S, Matboli M, Hegazy MG, Kotb YM and
Essawy NO: Evaluation of urinary microRNA panel in bladder cancer
diagnosis: Relation to bilharziasis. Transl Res. 165:731–739. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Cheng Y, Xiang G, Meng Y and Dong R:
MiRNA-183-5p promotes cell proliferation and inhibits apoptosis in
human breast cancer by targeting the PDCD4. Reprod Biol.
16:225–233. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wang ZY, Xiong J, Zhang SS, Wang JJ, Gong
ZJ and Dai MH: Up-regulation of microRNA-183 promotes cell
proliferation and invasion in glioma by directly targeting NEFL.
Cell Mol Neurobiol. 36:1303–1310. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wang J, Wang X, Li Z, Liu H and Teng Y:
MicroRNA-183 suppresses retinoblastoma cell growth, invasion and
migration by targeting LRP6. FEBS J. 281:1355–1365. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Goeppert B, Schmezer P, Dutruel C, Oakes
C, Renner M, Breinig M, Warth A, Vogel MN, Mittelbronn M, Mehrabi
A, et al: Down-regulation of tumor suppressor A kinase anchor
protein 12 in human hepatocarcinogenesis by epigenetic mechanisms.
Hepatology. 52:2023–2033. 2010. View Article : Google Scholar : PubMed/NCBI
|
